R3A- Investigador/a Sènior
Deadline: May 29th, 2026, 3:00 pm
About the Unit / Group
The Cancer Epigenetics Group focuses its research on establishing epigenomic and epitranscriptomic maps for normal and transformed cells, studying the interactions between epigenetic modifications and non-coding RNAs, and developing new epigenetic drugs for cancer treatment. The research plan for the coming years will expand and innovate the group’s previous key contributions in the fields of epigenetics and epitranscriptomics, both at the basic and translational levels, addressing the identity of organs, tissues and cells and how these features become deregulated in disease, with a main focus on cancer.
Main research lines:
- Study the “language” of chemical modifications in DNA and histones (Epigenetics) and RNA (Epitranscriptomics).
- Resolve multi-omic heterogeneity using a single-cell epigenetic approach.
- Elucidate the interaction between RNA modifications and carcinogenesis.
- Identify therapeutic vulnerabilities in cancer for epigenetic and epitranscriptomic drugs.
Essential requirements
- Minimum required qualification: PhD degree (obtained more than 5 years ago).
- High degree of demonstrated independence in research focused on epigenetics and molecular mechanisms of cancer within a research group, with relevant and continuous scientific production.
- Extensive experience and ability to participate in and/or lead one or more research projects.
- Experience in supervising and training junior research staff.
- High level of English and computer skills.
- Oral and written knowledge of the two official languages of Catalonia or, alternatively, the selected candidate must demonstrate or commit to acquiring an adequate command of both official languages within a period not exceeding one year. Skills will be valued
- Knowledge of molecular genetics.
- Knowledge of cell biology.
Functions
- Develop experiments to study cancer epigenetics.
- Develop experiments to study the cancer epitranscriptome.
- Contribute to the group’s collaborative projects.
- Supervise and mentor young researchers.
- Participate in and/or lead one or more research projects. Offered
- Contract linked to the project “Tumour-host interactions in liver cancer of childhood and adults (THRIVE)"
- Annual working schedule of 1,627.50 hours (37.5 hours/week).
- Salary according to collective agreement.
- Research Group: Cancer Epigenetics. Documentation and deadline for submission Interested parties should preferably deliver the documentation (1) in PDF, by e-mail to the Management of the Santa Creu i Sant Pau Hospital Research Institute Foundation, address ir_seleccio@santpau.cat , indicating the reference 2026/069: (1) Application letter and updated Curriculum Vitae and signed Data Processing Authorization** At the request of the Santa Creu i Sant Pau Hospital Research Institute Foundation, the candidates must present the documentation accrediting the merits mentioned in the curriculum vitae.